Unknown

Dataset Information

0

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.


ABSTRACT: Fusion genes involving ZNF384 have recently been identified in B-cell precursor acute lymphoblastic leukemia, and 7 fusion partners have been reported. We further characterized this type of fusion gene by whole transcriptome sequencing and/or polymerase chain reaction. In addition to previously reported genes, we identified BMP2K as a novel fusion partner for ZNF384 Including the EP300-ZNF384 that we reported recently, the total frequency of ZNF384-related fusion genes was 4.1% in 291 B-cell precursor acute lymphoblastic leukemia patients enrolled in a single clinical trial, and TCF3-ZNF384 was the most recurrent, with a frequency of 2.4%. The characteristic immunophenotype of weak CD10 and aberrant CD13 and/or CD33 expression was revealed to be a common feature of the leukemic cells harboring ZNF384-related fusion genes. The signature gene expression profile in TCF3-ZNF384-positive patients was enriched in hematopoietic stem cell features and related to that of EP300-ZNF384-positive patients, but was significantly distinct from that of TCF3-PBX1-positive and ZNF384-fusion-negative patients. However, clinical features of TCF3-ZNF384-positive patients are markedly different from those of EP300-ZNF384-positive patients, exhibiting higher cell counts and a younger age at presentation. TCF3-ZNF384-positive patients revealed a significantly poorer steroid response and a higher frequency of relapse, and the additional activating mutations in RAS signaling pathway genes were detected by whole exome analysis in some of the cases. Our observations indicate that ZNF384-related fusion genes consist of a distinct subgroup of B-cell precursor acute lymphoblastic leukemia with a characteristic immunophenotype, while the clinical features depend on the functional properties of individual fusion partners.

SUBMITTER: Hirabayashi S 

PROVIDER: S-EPMC5210242 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.

Hirabayashi Shinsuke S   Ohki Kentaro K   Nakabayashi Kazuhiko K   Ichikawa Hitoshi H   Momozawa Yukihide Y   Okamura Kohji K   Yaguchi Akinori A   Terada Kazuki K   Saito Yuya Y   Yoshimi Ai A   Ogata-Kawata Hiroko H   Sakamoto Hiromi H   Kato Motohiro M   Fujimura Junya J   Hino Moeko M   Kinoshita Akitoshi A   Kakuda Harumi H   Kurosawa Hidemitsu H   Kato Keisuke K   Kajiwara Ryosuke R   Moriwaki Koichi K   Morimoto Tsuyoshi T   Nakamura Kozue K   Noguchi Yasushi Y   Osumi Tomoo T   Sakashita Kazuo K   Takita Junko J   Yuza Yuki Y   Matsuda Koich K   Yoshida Teruhiko T   Matsumoto Kenji K   Hata Kenichiro K   Kubo Michiaki M   Matsubara Yoichi Y   Fukushima Takashi T   Koh Katsuyoshi K   Manabe Atsushi A   Ohara Akira A   Kiyokawa Nobutaka N  

Haematologica 20160915 1


Fusion genes involving ZNF384 have recently been identified in B-cell precursor acute lymphoblastic leukemia, and 7 fusion partners have been reported. We further characterized this type of fusion gene by whole transcriptome sequencing and/or polymerase chain reaction. In addition to previously reported genes, we identified BMP2K as a novel fusion partner for ZNF384 Including the EP300-ZNF384 that we reported recently, the total frequency of ZNF384-related fusion genes was 4.1% in 291 B-cell pre  ...[more]

Similar Datasets

| S-EPMC10272635 | biostudies-literature
| S-EPMC3389344 | biostudies-literature
| S-EPMC7536166 | biostudies-literature
| S-EPMC9474531 | biostudies-literature
| S-EPMC9414741 | biostudies-literature
| S-EPMC5685720 | biostudies-literature
| S-EPMC8447276 | biostudies-literature
| S-EPMC7605595 | biostudies-literature
| S-EPMC7469918 | biostudies-literature
| S-EPMC5728462 | biostudies-literature